Skip to menu Skip to content Skip to footer
Dr Sumaira Hasnain
Dr

Sumaira Hasnain

Email: 

Overview

Background

A/Prof Sumaira Hasnain graduated with her PhD in December 2010 from The University of Manchester and is an Associate Professor at Mater Research with a team of eight researchers. A/Prof Hasnain was the first globally to demonstrate that immunity can modulate protein production in secretory cells in infection and chronic diseases. Her long-term vision has been to characterise these novel immune factors and manipulate them therapeutically using pre-clinical models of immune-driven pathologies.

A/Prof Hasnain holds a patent for targeted immunotherapy in metabolic disease which has led to the formation of a spin-off company, Jetra Therapeutics and venture capitalist funding. She has a rapid upward trajectory in research, evident by extensive body of high-quality publications including in Nature Medicine, Nature Communications, Journal of Experimental Medicine, Oncogene and Gastroenterology. She has been awarded more than $9 million in competitive funding and recently gained the National Health and Medical Research Council L1 Investigator Grant. A/Prof Hasnain has won 21 awards to date, including the Commercialisation award from The University of Queensland in 2022 and the Gastroenterological Society for Australasia; Lawrie Powell Award in 2023.

Availability

Dr Sumaira Hasnain is:
Available for supervision
Media expert

Qualifications

  • Doctor of Philosophy, The University of Manchester

Research interests

  • Understanding Immune Regulation of Cellular Stress

    Using different disease models to target cellular stress and alleviate pathology

Research impacts

We have recently described for the first time that cytokines have the ability to stop or promote protein biosynthesis via the regulation of endoplasmic reticulum (ER) stress and oxidative stress. We are targetting the immune system to repair abnormal cellular protein secretion in conditions such as diabetes, which affects 1 in 20 Australians and inflammatory bowel disease, which affects 1 in 250 Australians. This research also has implications for other diseases and infections that have a high burden on the healthcare system. The ultimate aim of this research is to devise new strategies for treatments to aid recovery following infections and to alleviate chronic inflammatory disease.

Works

Search Professor Sumaira Hasnain’s works on UQ eSpace

87 works between 2010 and 2024

61 - 80 of 87 works

2015

Conference Publication

High fat diet and the colonic mucus barrier: implications for obesity and inflammatory bowel disease

Gulhane, M., Murray, L., Wang, R., Tong, H., Mcguckin, M. and Hasnain, S. (2015). High fat diet and the colonic mucus barrier: implications for obesity and inflammatory bowel disease. Gastro 2015 GESA-AGW and WGO International Congress, Gastroenterological Society of Australia Australian Gastroenterology Week 2015 | World Congress of Gastroenterology, Brisbane, Queensland, Australia, 28 September-2 October 2015. Richmond, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/jgh.13094

High fat diet and the colonic mucus barrier: implications for obesity and inflammatory bowel disease

2014

Journal Article

Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stress

Hasnain, Sumaira Z., Borg, Danielle J., Harcourt, Brooke E., Tong, Hui, Sheng, Yonghua H., Ng, Choa Ping, Das, Indrajit, Wang, Ran, Chen, Alice C.-H., Loudovaris, Thomas, Kay, Thomas W., Thomas, Helen E., Whitehead, Jonathan P., Forbes, Josephine M., Prins, Johannes B. and McGuckin, Michael A. (2014). Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stress. Nature Medicine, 20 (12), 1417-1426. doi: 10.1038/nm.3705

Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stress

2014

Journal Article

ZAP-70 genotype disrupts the relationship between microbiota and host leading to spondyloarthritis and ileitis in SKG Mice

Rehaume, Linda, Mondot, Stanislas, Aguirre de Cárcer, Daniel, Velasco, Jared, Benham, Helen, Hasnain, Sumaira Zia, Bowman, Jaclyn, Ruutu, Merja, Hansbro, Philip M., McGuckin, Michael, Morrison, Mark and Thomas, Ranjeny (2014). ZAP-70 genotype disrupts the relationship between microbiota and host leading to spondyloarthritis and ileitis in SKG Mice. Arthritis and Rheumatology, 66 (10), 2780-2792. doi: 10.1002/art.38773

ZAP-70 genotype disrupts the relationship between microbiota and host leading to spondyloarthritis and ileitis in SKG Mice

2014

Journal Article

Interleukin-23 mediates the intestinal response to microbial beta-glucan and the development of spondyloarthritis pathology in SKG mice

Benham, Helen, Rehaume, Linda M., Hasnain, Sumaira Z., Velasco, Jared, Baillet, Athan C., Ruutu, Merja, Kikly, Kristine, Wang, Ran, Tseng, Hsu-Wen, Thomas, Gethin P., Brown, Matthew A., Strutton, Geoffrey, McGuckin, Michael A. and Thomas, Ranjeny (2014). Interleukin-23 mediates the intestinal response to microbial beta-glucan and the development of spondyloarthritis pathology in SKG mice. Arthritis and Rheumatology, 66 (7), 1755-1767. doi: 10.1002/art.38638

Interleukin-23 mediates the intestinal response to microbial beta-glucan and the development of spondyloarthritis pathology in SKG mice

2014

Conference Publication

Human Neutrophil Elastase Activity and Matrix Metalloproteinase Activity Are Markers of Disease Severity in Non-Cf Bronchiectasis

Chen, A., Lourie, R., Martin, M., Burr, L., Hasnain, S., Fantino, E., Bowler, S., Mcguckin, M. and Serisier, D. (2014). Human Neutrophil Elastase Activity and Matrix Metalloproteinase Activity Are Markers of Disease Severity in Non-Cf Bronchiectasis. Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science 2014 Annual Scientific Meetings, Adelaide Australia, 4-9 April 2014. Richmond, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/resp.12263_6

Human Neutrophil Elastase Activity and Matrix Metalloproteinase Activity Are Markers of Disease Severity in Non-Cf Bronchiectasis

2014

Conference Publication

Direct Adverse Effects of IL-23 on Epithelial Cells Underline Greater Efficacy of Neutralizing IL-23 in Suppressing Murine Colitis

Wang, Ran, Hasnain, Sumaira Z., Tong, Hui, Lourie, Rohan, Florin, Timothy H. and McGuckin, Michael A. (2014). Direct Adverse Effects of IL-23 on Epithelial Cells Underline Greater Efficacy of Neutralizing IL-23 in Suppressing Murine Colitis. 55th Annual Meeting of the Society for Surgery of the Alimentary Tract (SSAT) / Digestive Disease Week (DDW), Chicago, Il, United States, May 03-06, 2014. Maryland Heights, MO, United States: W.B. Saunders Co.. doi: 10.1016/S0016-5085(14)62987-5

Direct Adverse Effects of IL-23 on Epithelial Cells Underline Greater Efficacy of Neutralizing IL-23 in Suppressing Murine Colitis

2014

Conference Publication

IL-23 and IL-24 Upregulate Pro-Inflammatory Chemokine Genes in Colonic Epithelial Cells

Lourie, R., Hasnain, S. Z., McGuckin, M. A. and Florin, T. H. (2014). IL-23 and IL-24 Upregulate Pro-Inflammatory Chemokine Genes in Colonic Epithelial Cells. 103rd Annual Meeting of the United States and Canadian Academy of Pathology (USCAP), San Diego, California, 1-7 March 2014. London, United Kingdom: Nature Publishing Group.

IL-23 and IL-24 Upregulate Pro-Inflammatory Chemokine Genes in Colonic Epithelial Cells

2014

Conference Publication

Clinical Benefits of Long-Term, Low-Dose Erythromycin in Bronchiectasis Are Not Due to Modulation of Sputum Mucin Content

Chen, A., Martin, M., Lourie, R., Burr, L., Hasnain, S., Bowler, S., Mcguckin, M. and Serisier, D. (2014). Clinical Benefits of Long-Term, Low-Dose Erythromycin in Bronchiectasis Are Not Due to Modulation of Sputum Mucin Content. Annual Scientific Meeting of the Thoracic Society of Australia and New Zealand and the Australian and New Zealand Society of Respiratory Science 2014, Adelaide, SA Australia, 4-9 April 2014. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/resp.12263_6

Clinical Benefits of Long-Term, Low-Dose Erythromycin in Bronchiectasis Are Not Due to Modulation of Sputum Mucin Content

2014

Conference Publication

IL-22 May Maintain Colonic Mucosal Barrier Function by Overriding ROS-Induced ER Stress and Chemokine Production in Colonic Epithelial Cells

Lourie, Rohan, Hasnain, Sumaira Z., McGuckin, Michael A. and Florin, Timothy H. (2014). IL-22 May Maintain Colonic Mucosal Barrier Function by Overriding ROS-Induced ER Stress and Chemokine Production in Colonic Epithelial Cells. Digestive Disease Week 2014, Chicago, Illinois, 3-6 May 2014. Maryland Heights, MO, United States: W.B. Saunders Co..

IL-22 May Maintain Colonic Mucosal Barrier Function by Overriding ROS-Induced ER Stress and Chemokine Production in Colonic Epithelial Cells

2013

Conference Publication

Administration Of E-Selectin Antagonist GMI-1271 Improves Survival After High-Dose Chemotherapy By Alleviating Mucositis and Accelerating Neutrophil Recovery

Winkler, Ingrid G., Barbier, Valerie, Nutt, Heather L., Hasnain, Sumaira Z., Levesque, Jean-Pierre, Magnani, John L. and McGuckin, Michael A. (2013). Administration Of E-Selectin Antagonist GMI-1271 Improves Survival After High-Dose Chemotherapy By Alleviating Mucositis and Accelerating Neutrophil Recovery. 55th Annual Meeting of the American-Society-of-Hematology, New Orleans La, Dec 07-10, 2013. WASHINGTON: AMER SOC HEMATOLOGY.

Administration Of E-Selectin Antagonist GMI-1271 Improves Survival After High-Dose Chemotherapy By Alleviating Mucositis and Accelerating Neutrophil Recovery

2013

Journal Article

Glucocorticoids alleviate intestinal ER stress by enhancing protein folding and degradation of misfolded proteins

Das, Indrajit, Png, Chin Wen, Oancea, Iulia, Hasnain, Sumaira Z., Lourie, Rohan, Proctor, Martina, Eri, Rajaraman D., Sheng, Yong, Crane, Denis I., Florin, Timothy H. and McGuckin, Michael A. (2013). Glucocorticoids alleviate intestinal ER stress by enhancing protein folding and degradation of misfolded proteins. Journal of Experimental Medicine, 210 (6), 1201-1216. doi: 10.1084/jem.20121268

Glucocorticoids alleviate intestinal ER stress by enhancing protein folding and degradation of misfolded proteins

2013

Journal Article

IL-10 promotes production of intestinal mucus by suppressing protein misfolding and endoplasmic reticulum stress in goblet cells

Hasnain, Sumaira Z., Tauro, Sharyn, Das, Indrajit, Tong, Hui, Chen, Alice C. -H., Jeffery, Penny L., McDonald, Victoria, Florin, Timothy H. and McGuckin, Michael A. (2013). IL-10 promotes production of intestinal mucus by suppressing protein misfolding and endoplasmic reticulum stress in goblet cells. Gastroenterology, 144 (2), 357-368. doi: 10.1053/j.gastro.2012.10.043

IL-10 promotes production of intestinal mucus by suppressing protein misfolding and endoplasmic reticulum stress in goblet cells

2013

Journal Article

There is a 'uc' in mucus, but is there mucus in UC?

McGuckin, Michael A. and Hasnain, Sumaira Z. (2013). There is a 'uc' in mucus, but is there mucus in UC?. Gut, 63 (2), 216-217. doi: 10.1136/gutjnl-2013-304602

There is a 'uc' in mucus, but is there mucus in UC?

2013

Journal Article

A new role for mucins in immunity: insights from gastrointestinal nematode infection

Hasnain, Sumaira Z., Gaagher, Amanda L., Grencis, Richard K. and Thornton, David J. (2013). A new role for mucins in immunity: insights from gastrointestinal nematode infection. International Journal of Biochemistry and Cell Biology, 45 (2), 364-374. doi: 10.1016/j.biocel.2012.10.011

A new role for mucins in immunity: insights from gastrointestinal nematode infection

2013

Conference Publication

Host Genetic Background Disrupts The Relationship Between Microbiota and Gut Mucosal Tolerance Leading To Spondyloarthritis and Ileitis After a Dectin-1 Trigger.

Rehaume, Linda, Mondot, Stanislas, Aguirre de Cárcer, D., Velasco, Jared, Benham, Helen, Hasnain, Sumaira, Bowman, Jaclyn, Ruutu, Merja, Hansbro, Philip, McGuckin, Michael, Morrison, Mark and Thomas, Ranjeny (2013). Host Genetic Background Disrupts The Relationship Between Microbiota and Gut Mucosal Tolerance Leading To Spondyloarthritis and Ileitis After a Dectin-1 Trigger.. 77th Annual Meeting of the American College of Rheumatology / 48th Annual Meeting of the Association of Rheumatology Health Professionals, San Diego Ca, 25-30 October 2013. Hoboken, NJ United States: John Wiley and Sons Inc.. doi: 10.1002/art.38216

Host Genetic Background Disrupts The Relationship Between Microbiota and Gut Mucosal Tolerance Leading To Spondyloarthritis and Ileitis After a Dectin-1 Trigger.

2013

Conference Publication

Incidence and Severity of Spondyloarthritis and Ileitis Are Determined by Interaction Between the Microbiota and Genetic Susceptibility in Beta-Glucan-Treated Skg Mice

Rehaume, L., Mondot, S., Aguirre de Cárcer, D., Velasco, J., Benham, H., Hasnain, S., Ruutu, M., McGuckin, M. and Morrison, M. (2013). Incidence and Severity of Spondyloarthritis and Ileitis Are Determined by Interaction Between the Microbiota and Genetic Susceptibility in Beta-Glucan-Treated Skg Mice. 54th Annual Scientific Meeting of the Australian Rheumatology Association in conjunction with the Rheumatology Health Professionals Association, Perth, WA Australia, 18 -22 May 2013. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/imj.12139

Incidence and Severity of Spondyloarthritis and Ileitis Are Determined by Interaction Between the Microbiota and Genetic Susceptibility in Beta-Glucan-Treated Skg Mice

2013

Conference Publication

Innate defences at mucosal barriers: the anti-parasitic potential of the purified gastric mucin MUC5AC

Gallagher, A. L., Gonzalez, F. Melo, Rousseau, K., Hasnain, S. Z., Thornton, D. J. and Grencis, R. K. (2013). Innate defences at mucosal barriers: the anti-parasitic potential of the purified gastric mucin MUC5AC. Annual Congress of the British-Society-for-Immunology, Liverpool England, Dec 02-05, 2013. HOBOKEN: WILEY-BLACKWELL.

Innate defences at mucosal barriers: the anti-parasitic potential of the purified gastric mucin MUC5AC

2013

Conference Publication

Clinical Benefits Of Long-Term, Low-Dose Erythromycin In Bronchiectasis Are Not Due To Anti-Inflammatory Effects

Chen, A. C., Martin, M. M., Burr, L., Hasnain, S. Z., Lourie, R., Bowler, S. D., McGuckin, M. A. and Serisier, D. J. (2013). Clinical Benefits Of Long-Term, Low-Dose Erythromycin In Bronchiectasis Are Not Due To Anti-Inflammatory Effects. American Thoracic Society 2013 International Conference, Philadelphia, Pennsylvania, 17-22 May 2013. New York, NY, United States: American Thoracic Society.

Clinical Benefits Of Long-Term, Low-Dose Erythromycin In Bronchiectasis Are Not Due To Anti-Inflammatory Effects

2012

Journal Article

Serine protease(s) secreted by the nematode Trichuris muris degrade the mucus barrier

Hasnain, Sumaira Z., McGuckin, Michael A., Grencis, Richard K. and Thornton, David J. (2012). Serine protease(s) secreted by the nematode Trichuris muris degrade the mucus barrier. PLoS Neglected Tropical Diseases, 6 (10) e1856, e1856.1-e1856.13. doi: 10.1371/journal.pntd.0001856

Serine protease(s) secreted by the nematode Trichuris muris degrade the mucus barrier

2012

Conference Publication

Intestinal Endoplasmic Reticulum Stress is Modulated by Inflammatory Cytokines

Hasnain, Sumaira Z., Tauro, Sharyn, Jeffery, Penny, Das, Indrajit, Tran, Thu V., Florin, Timothy H. and McGuckin, Michael A. (2012). Intestinal Endoplasmic Reticulum Stress is Modulated by Inflammatory Cytokines. Digestive Disease Week (DDW), San Diego Ca, May 19-22, 2012. PHILADELPHIA: W B SAUNDERS CO-ELSEVIER INC.

Intestinal Endoplasmic Reticulum Stress is Modulated by Inflammatory Cytokines

Funding

Current funding

  • 2025 - 2029
    Unlocking the Therapeutic Potential of Interleukin-22
    NHMRC Investigator Grants
    Open grant

Past funding

  • 2022 - 2023
    Can Targeting Interleukin-24 Resolve Intestinal Fibrosis in Inflammatory Bowel Disease?
    GESA Dr Falk Pharma Research Grant
    Open grant
  • 2020 - 2021
    Jetra/IL-22 - Project 2 - Skin toxicity, PK, dose and frequency finding studies
    UniQuest Pty Ltd
    Open grant
  • 2020
    Jetra/IL-22 - Project 1 - Confirm protein activity and human tissue profiling
    UniQuest Pty Ltd
    Open grant
  • 2020 - 2022
    Liver targeted Interleukin-22 for the treatment of non-alcoholic steatohepatitis
    NHMRC IDEAS Grants
    Open grant
  • 2019 - 2020
    Interleukin-22: New Therapeutic Target Against Viral Infections in Children
    The Children's Hospital Foundation
    Open grant
  • 2018 - 2019
    IL-22-based therapy ameliorates liver steatosis
    Gastroenterological Society of Australia
    Open grant
  • 2018 - 2022
    Targeting Immunopathology in Chronic Diseases
    NHMRC Career Development Fellowship
    Open grant
  • 2016 - 2017
    Elucidation of the Mechanism of IL-22-Mediated Suppression of Beta-Cell Stress in Diabetes
    NHMRC Project Grant
    Open grant
  • 2016
    Understanding cytokine regulation of oxidative and ER stress in infectious and inflammatory disease
    UQ Early Career Researcher
    Open grant
  • 2015 - 2017
    Cytokine Modulation of Secretory Cell Function via Oxidative and Endoplasmic Reticulum Stress in Infection and Inflammation
    UQ Postdoctoral Research Fellowship
    Open grant
  • 2015 - 2019
    IL-22 as a Suppressor of Pancreatic Beta-Cell Stress and a Treatment for Diabetes
    NHMRC Project Grant
    Open grant
  • 2015
    Pancreatic targeting of IL-22 therapy for diabetes
    UQ Collaboration and Industry Engagement Fund - Seed Research Grant
    Open grant
  • 2014 - 2015
    A new approach to tackling chemotherapy-induced mucositis
    Cancer Council Queensland
    Open grant
  • 2013 - 2015
    ER Stress as a Contributing Factor in Inflammatory Disease
    NHMRC Project Grant
    Open grant

Supervision

Availability

Dr Sumaira Hasnain is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Available projects

  • Disrupting Immune Responses to Reverse Fibrosis

    Biomedical and clinical sciences

    Project description

    Intestinal fibrosis is a debilitating complication affecting a significant portion of patients with Inflammatory Bowel Disease (IBD), including Ulcerative Colitis (UC) and Crohn's Disease (CD). Chronic inflammation within the intestinal tract leads to excessive collagen production by fibroblasts, resulting in luminal narrowing, obstruction, and a significant decline in quality of life.

    Recent studies have suggested a potential role for interleukin-24 (IL-24) in the pathogenesis of IBD. IL-24 is a cytokine with both pro-inflammatory and anti-inflammatory properties, and it has been implicated in various fibrotic diseases.

    This research aims to investigate the specific role of IL-24 in driving intestinal fibrosis in IBD, with a particular focus on its ability to activate transforming growth factor-beta (TGF-beta), a key mediator of fibrosis.

    Specific Research Questions:

    1. Expression of IL-24 and TGF-beta in fibrotic intestinal tissue: Are IL-24 and TGF-beta upregulated in fibrotic regions of the intestine in IBD patients?
    2. IL-24-mediated activation of TGF-beta: Does IL-24 directly or indirectly stimulate the production and activation of TGF-beta in intestinal fibroblasts?
    3. Role of TGF-beta in IL-24-induced fibrosis: What are the downstream effects of TGF-beta activation in promoting intestinal fibrosis?
    4. Therapeutic potential of targeting IL-24 or TGF-beta: Can inhibiting IL-24 or TGF-beta pathways be a potential therapeutic strategy for preventing or treating intestinal fibrosis in IBD?

  • The Link Between Cellular Stress and Antigen Presentation

    The endoplasmic reticulum (ER) plays a crucial role in the production and presentation of MHC Class II antigens, which are essential for the immune system to recognize and eliminate foreign invaders. When proteins are misfolded or improperly assembled in the ER, it can trigger a cellular stress response known as ER stress. This stress can impact the generation and presentation of MHC Class II antigens in several ways. Our focus has been on antigen presentation by nonprofessional antigen presenting cells like epithelial cells. Project Aim: To investigate the complex relationship between protein misfolding, ER stress, and MHC Class II antigen presentation, with a focus on understanding how these factors influence the development of immune responses, particularly those involving CD4+ T cells. Expected outcomes and deliverables: This project will be undertaken at UQ (Mater Research Institute) within the Translational Research Institute (TRI) which is a collaborative building that incorporates over 1200 research scientists and students. TRI also provides an exceptional research environment with access to state-of-art facilities including flow cytometry, microscopy and a strong network of research support professionals. There is support for PhD students, through UQ as well as Mater Student Committee (sMater). The honours student will learn a range of techniques, in particular, flow cytometry, histology, Confocal Microscopy and preclinical animal work. There is a potential of extending the honours project into a PhD project.

  • Decoding the IL-22RA1-Insulin Biosynthesis Link: A New Target for Diabetes

    The IL-22RA1 receptor is abundant in the pancreas, and external IL-22 has been shown to improve pancreatic islet health and insulin secretion. However, the natural function of IL-22RA1 signalling within these cells is incompletely understood. Our recent work has shown that endogenous IL-22RA1 signalling in regulating insulin secretion, islet regeneration, and overall metabolic health. Understanding the specific mechanisms involved in IL-22RA1-mediated regulation of pancreatic beta cell function could lead to novel therapeutic strategies for diabetes and other metabolic disorders. This project will focus on investigating the exact mechanisms by which IL-22 regulates these processes, with a particular focus on calcium storage and cytoskeletal changes. Expected outcomes and deliverables: This project will be undertaken at UQ (Mater Research Institute) within the Translational Research Institute (TRI) which is a collaborative building that incorporates over 1200 research scientists and students. TRI also provides an exceptional research environment with access to state-of-art facilities including flow cytometry, microscopy and a strong network of research support professionals. There is support for PhD students, through UQ as well as Mater Student Committee (sMater). The honours student will learn a range of techniques, in particular, flow cytometry, histology, Confocal Microscopy and preclinical animal work. There is a potential of extending the honours project into a PhD project.

Supervision history

Current supervision

  • Doctor Philosophy

    Decline of Unfolded Protein Response with Age Increases Susceptibility to Infection and Inflammation

    Principal Advisor

    Other advisors: Associate Professor Lucy Burr

  • Doctor Philosophy

    Achieving Remission in Asthma

    Associate Advisor

    Other advisors: Associate Professor Lucy Burr

Completed supervision

Media

Enquiries

Contact Dr Sumaira Hasnain directly for media enquiries about:

  • Cellular Stress
  • Immune System
  • Infectious Diseases

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au